Bryan Giraudo's Net Worth
Bryan Giraudo's net worth is estimated to be at least $675,759.87 as of 12/23/2024. CoreStreet's estimation of Bryan Giraudo's net worth is based on their sale of stock and current holding of stock.
Bryan Giraudo is CFO at Gossamer Bio Inc. They have executed at least 13 trades of stock as per SEC Form 4 filings. Their most recent trade was for 6,430 units of GOSS stock on 03/27/2024. Their biggest sale was on 03/23/2021 when they sold 5,490 units of Gossamer Bio Inc stock for $52,045.20. They typically trade 1 times per year.
Total value of insider buys:
- $616,255.87
Total value of insider sells:
- $59,504.00
Most recent insider trade:
- March 27, 2024
Bryan Giraudo's Insider Trading History
| Gossamer Bio Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
March 27, 2024 | CFO | 6,430 | $1.16 | Sell | $7,458.80 |
Nov. 13, 2023 | CFO | 200,000 | $0.56 | Buy | $112,000.00 |
April 4, 2023 | CFO | 55,000 | $1.02 | Buy | $56,100.00 |
March 20, 2023 | CFO | 50,000 | $0.97 | Buy | $48,500.00 |
July 15, 2022 | CFO | 13,869 | $7.21 | Buy | $99,995.49 |
March 23, 2021 | CFO | 5,490 | $9.48 | Sell | $52,045.20 |
Oct. 14, 2020 | CFO | 3,000 | $10.01 | Buy | $30,030.00 |
June 23, 2020 | CFO | 2,000 | $12.96 | Buy | $25,920.00 |
Sept. 26, 2019 | CFO | 1,121 | $16.78 | Buy | $18,810.38 |
May 30, 2019 | CFO | 1,000 | $18.70 | Buy | $18,700.00 |
Feb. 12, 2019 | CFO | 6,000 | $16.00 | Buy | $96,000.00 |
| Protagonist Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 3, 2019 | Director | 8,000 | $5.70 | Buy | $45,600.00 |
May 16, 2018 | Director | 10,000 | $6.46 | Buy | $64,600.00 |